A prospective randomized trial of remote renal ischemic preconditioning for reducing nephropathy risk following fenestrated endovascular aortic aneurysm repair
Journal of Vascular Surgery · 2025
DOI: 10.1016/j.jvs.2025.02.017 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Journal of Vascular Surgery, 2025. Verfasst von Kenneth Tran und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Vascular Surgery, Stanford Health Care, Stanford, CA; Cardiovascular Institute, Stanford University, Stanford, CA. Electronic address: Ke…. Hauptthemen laut MEDLINE: Endovascular Procedures, Ischemic Preconditioning, Acute Kidney Injury, Aortic Aneurysm, Abdominal. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 16 Literaturangaben.
Abstract (Originalsprache)
OBJECTIVES: We sought to evaluate whether remote renal ischemic preconditioning is effective for reducing postoperative acute kidney injury (AKI) and mid-term renal function decline in patients undergoing elective fenestrated endovascular aneurysm repair (FEVAR) of juxtarenal aortic aneurysms. METHODS: We performed a single-site, blinded, prospective randomized trial of a renal ischemic preconditioning intervention using arm ischemia via manual inflation of arm blood pressure cuff. We evaluated 30-day AKI, determined using the Risk, Injury, Failure, loss of Function, and End-stage (RIFLE) classification and 2-year freedom from renal function decline, defined as a >30% decrease in baseline estimated glomerular function rate. The study was powered to detect a >25% difference in renal injury incidence. RESULTS: We enrolled 80 patients (80% male; mean aneurysm diameter, 6.1 cm) who were undergoing elective FEVAR using Cook ZFEN devices between July 2018 and August 2023. The 30-day follow-up rate was 95.0%, and mean follow-up duration was 20.2 ± 14.6 months. Although there was a trend to older patient age in the treatment group (77.4 ± 7.8 years vs 74.1 ± 7.0 years), this difference did not reach statistical significance (P = .05). The mean baseline estimated glomerular function rate and creatinine were 69.8 ± 21.0 mL/min/1.73 m2 and 1.1 ± 0.4 mg/dL respectively, and 30.0% had chronic kidney disease stage ≥3. There were no differences in any other baseline or operative metrics between the groups. The rate of AKI at 30 days was 11.3% overall (risk, 7.5%; injury, 2.5%; failure, 1.3%) and did not differ between groups. There were no 30-day deaths. There was no difference in 2-year freedom from renal function decline between treatment groups (56.2% vs 81.1%; log-rank P = .12). CONCLUSIONS: Renal ischemic preconditioning using arm ischemia did not confer a 30-day AKI or mortality or long-term renal protection benefit in patients undergoing elective FEVAR.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Vascular Surgery, Stanford Health Care, Stanford, CA; Cardiovascular Institute, Stanford University, Stanford, CA. Electronic address: Kenneth.tran@stanford.edu.
- Division of Vascular Surgery, Stanford Health Care, Stanford, CA.
- Division of Vascular Surgery, Lausanne University Hospital, Lausanne, Switzerland.
- Division of Vascular Surgery, Stanford Health Care, Stanford, CA; Cardiovascular Institute, Stanford University, Stanford, CA.
Zitieren
APA
Tran, K., Dossabhoy, S., Adkar, S., Deslarzes-Dubuis, C., & Lee, J. (2025). A prospective randomized trial of remote renal ischemic preconditioning for reducing nephropathy risk following fenestrated endovascular aortic aneurysm repair. Journal of Vascular Surgery. https://doi.org/10.1016/j.jvs.2025.02.017
Vancouver
Tran K, Dossabhoy S, Adkar S, Deslarzes-Dubuis C, Lee J. A prospective randomized trial of remote renal ischemic preconditioning for reducing nephropathy risk following fenestrated endovascular aortic aneurysm repair. Journal of Vascular Surgery. 2025. doi:10.1016/j.jvs.2025.02.017
BibTeX
@article{Tran2025,
author = {Tran, Kenneth and Dossabhoy, Shernaz and Adkar, Shaunak and Deslarzes-Dubuis, Celine and Lee, Jason},
title = {A prospective randomized trial of remote renal ischemic preconditioning for reducing nephropathy risk following fenestrated endovascular aortic aneurysm repair},
journal = {Journal of Vascular Surgery},
year = {2025},
doi = {10.1016/j.jvs.2025.02.017}
}
EUVIMED